Ptosis and weakness after start of D-penicillamine therapy.
D001763:Blepharoptosis / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects*; D013997:Time Factors
D010396:Penicillamine